ATE370733T1 - Pharmazeutische kombinationspräparat zur behandlung von spastischkeit und/oder schmerzen - Google Patents

Pharmazeutische kombinationspräparat zur behandlung von spastischkeit und/oder schmerzen

Info

Publication number
ATE370733T1
ATE370733T1 AT04726223T AT04726223T ATE370733T1 AT E370733 T1 ATE370733 T1 AT E370733T1 AT 04726223 T AT04726223 T AT 04726223T AT 04726223 T AT04726223 T AT 04726223T AT E370733 T1 ATE370733 T1 AT E370733T1
Authority
AT
Austria
Prior art keywords
spasticity
treatment
pain
pharmaceutical combination
combination preparation
Prior art date
Application number
AT04726223T
Other languages
English (en)
Inventor
Karoly Tihanyi
Pal Kocsis
Gyoergy Nemeth
Istvan Tarnawa
Balazs Dalmadi
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Application granted granted Critical
Publication of ATE370733T1 publication Critical patent/ATE370733T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT04726223T 2003-04-09 2004-04-07 Pharmazeutische kombinationspräparat zur behandlung von spastischkeit und/oder schmerzen ATE370733T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0300929A HUP0300929A3 (en) 2003-04-09 2003-04-09 Analgetic and/or muscle relaxant pharmaceutical composition

Publications (1)

Publication Number Publication Date
ATE370733T1 true ATE370733T1 (de) 2007-09-15

Family

ID=90001682

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04726223T ATE370733T1 (de) 2003-04-09 2004-04-07 Pharmazeutische kombinationspräparat zur behandlung von spastischkeit und/oder schmerzen

Country Status (16)

Country Link
US (1) US20060199841A1 (de)
EP (1) EP1610785B1 (de)
JP (1) JP2006522786A (de)
AT (1) ATE370733T1 (de)
CY (1) CY1106903T1 (de)
DE (1) DE602004008440T2 (de)
DK (1) DK1610785T3 (de)
EA (1) EA007732B1 (de)
ES (1) ES2293245T3 (de)
HR (1) HRP20070441T3 (de)
HU (1) HUP0300929A3 (de)
NO (1) NO20055254L (de)
PL (1) PL1610785T3 (de)
PT (1) PT1610785E (de)
RS (1) RS20050738A (de)
WO (1) WO2004089352A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE491474T1 (de) * 2001-06-07 2011-01-15 Sang Christine Dr Behandlung von neuropathischen schmerzen mittels eines n-methyl-d-aspartate (nmda)-rezeptor- antagonists
US8262942B2 (en) 2008-02-07 2012-09-11 The George Washington University Hollow carbon nanosphere based secondary cell electrodes
TR201720289A2 (tr) * 2017-12-13 2019-06-21 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Tolperizon Ve Selektif COX-2 İnhibitörü Kombinasyonları
JP7169580B2 (ja) * 2018-09-27 2022-11-11 株式会社Ｌｔｔバイオファーマ 線維症治療用医薬組成物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5340779A (en) * 1976-09-21 1978-04-13 Nippon Kayaku Co Ltd Optically active tolpertisone, their preparation and pharmaceuticals containting the same
US4906638A (en) * 1987-12-22 1990-03-06 Nova Pharmaceutical Corporation Dextromethorphan potentiator for anticonvulsant composition and method
JPH02502546A (ja) * 1987-12-22 1990-08-16 ファーカニー、ジョン　ダブリュ 抗ひきつけ剤組成物および方法のためのデキストロルファン相乗的協力剤
US5206248A (en) * 1992-03-27 1993-04-27 Smith Richard A Method for reducing emotional lability
AU8071894A (en) * 1994-09-22 1996-04-09 Jonathan M Licht Compositions useful for the preparation of medicines for treating a variety of intractable disorders
US5840731A (en) * 1995-08-02 1998-11-24 Virginia Commonwealth University Pain-alleviating drug composition and method for alleviating pain
AUPN605795A0 (en) * 1995-10-19 1995-11-09 F.H. Faulding & Co. Limited Analgesic pharmaceutical composition
EP0942752B1 (de) * 1996-08-23 2005-04-20 Algos Pharmaceutical Corporation Antikonvulsive mitteln enthaltende zubereitung zur behandlung von neuropathischen schmerzen
AT409083B (de) * 1999-04-01 2002-05-27 Sanochemia Pharmazeutika Ag Pharmazeutische, tolperison enthaltende zubereitung zur oralen verabreichung
DE10123129A1 (de) * 2001-05-02 2002-11-14 Berolina Drug Dev Ab Svedala Deuterierte 3-Piperidinopropiophenone sowie diese Verbindungen enthaltende Arzneimittel

Also Published As

Publication number Publication date
DK1610785T3 (da) 2007-10-22
HRP20070441T3 (hr) 2007-10-31
NO20055254D0 (no) 2005-11-08
HUP0300929D0 (en) 2003-06-28
HUP0300929A3 (en) 2005-06-28
PT1610785E (pt) 2007-09-10
WO2004089352A3 (en) 2004-12-16
NO20055254L (no) 2006-01-06
EA007732B1 (ru) 2006-12-29
US20060199841A1 (en) 2006-09-07
RS20050738A (sr) 2008-04-04
DE602004008440D1 (de) 2007-10-04
PL1610785T3 (pl) 2008-01-31
DE602004008440T2 (de) 2008-05-21
JP2006522786A (ja) 2006-10-05
WO2004089352A2 (en) 2004-10-21
HUP0300929A2 (hu) 2005-02-28
CY1106903T1 (el) 2012-09-26
EP1610785A2 (de) 2006-01-04
ES2293245T3 (es) 2008-03-16
EP1610785B1 (de) 2007-08-22
EA200501591A1 (ru) 2006-06-30

Similar Documents

Publication Publication Date Title
GB0022438D0 (en) Organic Compounds
TW200615266A (en) Organic compounds
AP1822A (en) Substituted pyridinones as modulators of P38 MAP kinase.
TNSN04203A1 (en) Benzoxazinone-derived compounds, their preparation and use as medicaments
CY1109962T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4,5]δεκαν-2-ονης για τη θεραπεια παχυσαρκιας
UA85708C2 (ru) Лекарственные комбинации, содержащие бензоксазины, для лечения заболеваний дыхательных путей
ATE486587T1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
CY1109366T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης
DE502005008058D1 (de) Gesättigte und ungesättigte 3-pyridyl-benzocycloalkylmethyl-amine zur behandlung von schmerzen, depressionen und angstzuständen
EA200601846A1 (ru) Содержащие бензоксазины лекарственные комбинации для лечения заболеваний дыхательных путей
ATE502631T1 (de) Verbindungen zur behandlung von stoffwechselstörungen
ATE432936T1 (de) Imidazotriazin verbindungen zur behandlung von krebserkrankungen
NO20044531L (no) Imidazolinylmetyl-aralkylsulfonamider, blandinger omfattende slike, fremgangsmate for fremstilling av slike, slike forbindelser som medikament samt anvendelse av slike forbindelser for fremstilling av medikamenter for behandling av sykdom
CY1106903T1 (el) Φαρμακευτικος συνδυασμος για τη θεραπεια της σπαστικοτητας και/ή του πονου
GB0012795D0 (en) Organic compounds
TW200510379A (en) 1, 4-disubstituted piperidine compounds, their preparation and use as medicaments
DE502007006951D1 (de) Arzneimittelkombinationen zur behandlung von atemwegserkrankungen
DE60309926D1 (de) Steroid-verbindungen mit anti-tumoraler wirkung
ATE543495T1 (de) Pharmazeutische zusammensetzung mit einer ruthenium-oxalato-verbindung und anwendungsverfahren dafür
ATE401081T1 (de) Ammoniumsalze von ornithin-derivaten zur behandlung von enzündlichen erkrankungen
IS6416A (is) Fjórgild ammóníum og notkun þeirra sem miðlar gegn hósta
TH62500A (th) Nk1 แอนทาโกนิสท์
UA54880C2 (uk) Застосування (s)-2-аміно-5-гуанідинопентанової кислоти (s)-2-аміноглутарату (l-аргініну l-глутамат) як фармацевтичного препарату, що має гепатопротекторну та детоксикуючу дію, спосіб його одержання, фармацевтична композиція на його основі
SE0300117D0 (sv) Novel Compounds

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1610785

Country of ref document: EP

REN Ceased due to non-payment of the annual fee